0001562180-23-005762.txt : 20230706
0001562180-23-005762.hdr.sgml : 20230706
20230706161510
ACCESSION NUMBER: 0001562180-23-005762
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230630
FILED AS OF DATE: 20230706
DATE AS OF CHANGE: 20230706
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Weinberg Uri
CENTRAL INDEX KEY: 0001811030
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37565
FILM NUMBER: 231073748
MAIL ADDRESS:
STREET 1: NOVOCURE INC., 20 VALLEY STREAM PARKWAY
STREET 2: SUITE 300
CITY: MALVERN
STATE: PA
ZIP: 19355
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NovoCure Ltd
CENTRAL INDEX KEY: 0001645113
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: NO. 4 THE FORUM
STREET 2: GRENVILLE STREET
CITY: ST. HELIER
STATE: Y9
ZIP: JE2 4UF
BUSINESS PHONE: 44 (0)15 3475 6700
MAIL ADDRESS:
STREET 1: NO. 4 THE FORUM
STREET 2: GRENVILLE STREET
CITY: ST. HELIER
STATE: Y9
ZIP: JE2 4UF
FORMER COMPANY:
FORMER CONFORMED NAME: Novocure Ltd
DATE OF NAME CHANGE: 20150615
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0407
4
2023-06-30
false
0001645113
NovoCure Ltd
NVCR
0001811030
Weinberg Uri
C/O NOVOCURE INC.
1550 LIBERTY RIDGE DRIVE, SUITE 115
WAYNE
PA
19087
false
true
false
false
Chief Innovation Officer
false
Ordinary Shares
2023-06-30
5
A
false
E
305.00
35.28
A
89349.00
D
The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan ("ESPP"), for the ESPP purchase period of January1, 2023 through June 30, 2023. This transaction is also exempt under Rule 16b-3(c).
In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on June 30, 2023.
Steven Robbins, as attorney in fact for Weinberg, Uri
2023-07-06